Melinda Wuest

11560 University Avenue, T6G 1Z2
Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications

Sugar Amino Acid Linkers for the Design of [18F]SiFA-PSMA Radioligands.

Sugar Amino Acid Linkers for the Design of [18F]SiFA-PSMA Radioligands.

Journal: ChemMedChem
Published: April 27, 2026

68Ga-Labeled Peptides Targeting Oxytocin Receptor in Breast Cancer Using Linchpin Chemistry for Tandem Peptide Cyclization and Radiometal Chelator Incorporation.

68Ga-Labeled Peptides Targeting Oxytocin Receptor in Breast Cancer Using Linchpin Chemistry for Tandem Peptide Cyclization and Radiometal Chelator Incorporation.

Journal: Bioconjugate chemistry
Published: November 26, 2025

Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals.

Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals.

Journal: Journal of medicinal chemistry
Published: August 20, 2025

Synthesis and Evaluation of Fluorinated Peptidomimetics Enabling the Development of 18F-Labeled Radioligands Targeting Muscarinic Acetylcholine Receptor Subtype M3.

Synthesis and Evaluation of Fluorinated Peptidomimetics Enabling the Development of 18F-Labeled Radioligands Targeting Muscarinic Acetylcholine Receptor Subtype M3.

Journal: ChemMedChem
Published: July 08, 2025

Neuroendocrine tumour morphology and platelet derived growth factor receptor alpha expression.

Neuroendocrine tumour morphology and platelet derived growth factor receptor alpha expression.

Journal: Experimental and molecular pathology
Published: June 16, 2025

Optimized Radiosynthesis of the Ketone Body Radioligand (3S)-4-[18F]Fluoro-3-hydroxybutyric Acid ([18F]FBHB) for PET Imaging.

Optimized Radiosynthesis of the Ketone Body Radioligand (3S)-4-[18F]Fluoro-3-hydroxybutyric Acid ([18F]FBHB) for PET Imaging.

Journal: Organic letters
Published: June 11, 2025

Development and clinical potential of 18F-PSiMA for prostate cancer PET imaging.

Development and clinical potential of 18F-PSiMA for prostate cancer PET imaging.

Journal: RSC medicinal chemistry
Published: March 31, 2025

Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells.

Tackling Prostate Cancer with Theranostic E5B9-Bombesin Target Modules (TMs): From Imaging to Treatment with UniCAR T-Cells.

Journal: International journal of molecular sciences
Published: February 06, 2025

Immuno-PET Imaging of EGFR with 64Cu-NOTA Panitumumab in Subcutaneous and Metastatic Nonsmall Cell Lung Cancer Xenografts.

Immuno-PET Imaging of EGFR with 64Cu-NOTA Panitumumab in Subcutaneous and Metastatic Nonsmall Cell Lung Cancer Xenografts.

Journal: Molecular pharmaceutics
Published: October 15, 2024

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice.

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice.

Journal: EJNMMI radiopharmacy and chemistry
Published: August 20, 2024

First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α.

First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α.

Journal: Molecular pharmaceutics
Published: August 17, 2024

Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity.

Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity.

Journal: iScience
Published: August 15, 2024
Showing 1-12 of 80

Last Updated: 09/26/2026